National Institutes of Health (NIH) — 2019 Investments
253 investments dated 2019 · page 2 of 2 · listed companies and verified rows first · show all
RTM Vital Signs develops a small wearable device for continuous respiratory monitoring of hospital patients, aimed at detecting respiratory depression in patients receiving opioids for pain management.
Digital HealthHardwareHealthtechMedical DevicesFort Washington, US
Denise L. Devine(Executive Officer)Nance Dicciani(Executive Officer)
BiotechSunnyvale, US
Lawrence Wade Fry(Executive Officer, Director, Promoter)Jeanette Marie Mucha(Executive Officer, Director, Promoter)Anthony Cann Cann(Executive Officer, Director, Promoter)Derik Anthony Twomey(Director, Promoter)
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics.
BiotechDigital HealthHardwareHealthtechMedical DevicesDallas, US
Daniel Powell(President & Chief Executive Officer)inAlejandro Covalin, PhD(Chief Technology Officer)inNavid Khodaparast, PhD(Chief Science Officer)inAlejandro Covalin(Chief Technology Officer and Director)Navid Khodaparast(Chief Science Officer and Director)Ted Costopoulos(Director)
Subtle Medical develops deep learning software for medical imaging that enables faster and safer image acquisition on existing scanners for healthcare providers and imaging centers.
AI & Machine LearningHealthtechMedical Devices
Greg Zaharchuk(Co-founder, MD, Ph.D., Neuroradiologist and Professor at Stanford)inEnhao Gong(Co-founder, Ph.D., Deep Learning Scientist)in
Surgivance develops digital pathology imaging technology for analyzing tissue samples with rapid image capture and without calibration requirements.
AI & Machine LearningHealthtechMedical Devices
Tavo Biotherapeutics develops novel treatments for glaucoma and retinal diseases, focusing on disease-modifying therapies that target the root biological mechanisms of vision loss.
BiotechHealthtechMedical Devices
Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.
AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US
Jan Jensen(Founder)Joshua Snow(Chief Commercial Officer)Divya Trivedi(Chief Operating Officer and Secretary)David Llewellyn(President & CEO)Magnus Persson(Chairman)Josh Snow(Chief Commercial Officer)
Woebot Health builds chat-based AI wellness tools to provide mental health support to individuals and organizations.
AI & Machine LearningDigital HealthMental Health
Alison Darcy(Founder)
BiotechGreenville, US
Scott Rutledge Pancoast(Executive Officer, Director, Promoter)Thomas Patrick Murray(Executive Officer)Lance Michael White(Director)Gary J Atkinson(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.